Delivering Quality product is our responsibility and habit

At Doctivo we maintain stringent high importance to maintain stringent Quality Standards all across our processes and services to ensure that all our product meet the highest quality standards.

Our capabilities to meet the regulatory requirements of different countries, has enabled us to develop a rich and diverse product portfolio of branded formulations in Cephalosporins, NSAIDs, Probiotic & Rheumatoid Arthritis. Thus, we ensure that we meet customers’ requirements in Latin American, Southeast Asia, Africa and Middle East Countries.

We are making a conscious effort to expand our global footprint by having alliances with global players for collaborative research, marketing tie-ups and joint ventures to create synergies.

Our manufacturing facility is WHO and CGMP certified, are equipped to deliver a range of dosage delivery formats that include Capsules, Tablets, Injectables & Sachets, Cream & ointments, making us the preferred manufacturing partner for global pharmaceutical organizations.

Production Capacities

Tablets: 2894 million per annum
Capsules: 504 million per annum
In addition to the current solid oral dosage facility, Powder for Injection 202 million per annum,
Injection for Solution 210 million per annum.